New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine
In the meantime, practitioners of this new kind of mental healthcare can use ketamine as their psychedelic agent; and some studies, such as the one Grant participated in, are even government funded. The Ketamine for Reduction of Alcoholic Relapse (Kare) study is a novel attempt to ease the huge burden on the NHS caused by alcohol-related illnesses.
New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine Read More »